| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |